Africa is unlikely to meet its targets for vaccinating the continent against COVID-19 if supply delays from a key Indian manufacturer continue, the director of the Africa Centers for Disease Control and Prevention warned Thursday.
Dr. John Nkengasong told a press briefing that officials hope the problems at the Serum Institute of India will only be temporary otherwise “it would definitely impact our ability to continuously vaccinate people.”
“I really want to deliberately hope that it is a delay — not a ban — because that would be catastrophic,” he said.
